4//SEC Filing
Protea Biosciences Group, Inc. 4
Accession 0001144204-17-018872
CIK 0001335103operating
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 4:23 PM ET
Size
10.7 KB
Accession
0001144204-17-018872
Insider Transaction Report
Form 4
SEGAL SCOTT
Director
Transactions
- Other
Common Stock
2017-03-24+1,000,000→ 3,633,844 total - Other
Class A Warrant (right to buy)
2017-03-24+1,000,000→ 2,916,972 totalExercise: $0.09From: 2017-03-24Exp: 2018-09-24→ Common Stock (1,000,000 underlying) - Other
Class B Warrant (right to buy)
2017-03-24+1,000,000→ 2,916,972 totalExercise: $0.11From: 2017-03-24Exp: 2022-03-24→ Common Stock (1,000,000 underlying)
Footnotes (3)
- [F1]Mr. Segal held $75,000 of outstanding principal indebtedness and accrued unpaid interest of the Issuer ("Unsecured Debt"). On March 24, 2017, Mr. Segal exchanged $75,000 of Unsecured Debt of the Issuer, for units of the Issuer's equity securities, consisting of (a) an aggregate of 1,000,000 shares of common stock, $0.0001 par value per share, of the Issuer ("Common Stock") valued at $0.075 per share, (b) 18 month Class A warrants to purchase 1,000,000 shares of Common Stock at an exercise price of $0.09 per share, and (c) five year Class B warrants to purchase another 1,000,000 shares at an exercise price of $0.1125 per share.
- [F2]The shares of Common Stock reported in Column 5 and 7 are the number of shares of Common Stock issuable upon exercise of the Class A Warrant and/or Class B Warrant (collectively, "Warrants").
- [F3]Includes 2,500,305 shares of Common Stock to be acquired upon the exercise of warrants and 416,667 shares of common stock to be acquired upon the exercise of stock options.
Documents
Issuer
Protea Biosciences Group, Inc.
CIK 0001335103
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001335103
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 4:23 PM ET
- Size
- 10.7 KB